1-6 of 6
Stephen S. Opat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Open Access
Clinical Trials & Observations
Ramón García-Sanz, Roger G. Owen, Wojciech Jurczak, Meletios A. Dimopoulos, Helen McCarthy, Gavin Cull, Stephen S. Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cleary Cohen, Constantine S. Tam
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6538–6546.
https://doi.org/10.1182/bloodadvances.2024015596
Published: 2025
Journal Articles

Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

Open Access
Clinical Trials & Observations
Constantine S Tam, Mary Ann Anderson, Martin Simkovic, Paolo Ghia, Ian W. Flinn, Kamel Laribi, Stephen S. Opat, Gavin Cull, Talha Munir, Anders Österborg, Alessandra Tedeschi, Megan (Der Yu) Wang, Andy H. Szeto, Heather Allewelt, Tommi Salmi, Jessica Li, Linlin Xu, Kenneth Wu, Remus Vezan, Mazyar Shadman, Jennifer R. Brown
Journal: Blood Advances
Blood Adv bloodadvances.2025015986.
https://doi.org/10.1182/bloodadvances.2025015986
Published: 2025
Includes: Supplemental data
Journal Articles

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia

Open Access
Clinical Trials & Observations
Benjamin M. Heyman, Stephen S. Opat, Björn E. Wahlin, Meletios-Athanasios C. Dimopoulos, Jorge J. Castillo, Alessandra Tedeschi, Constantine S. Tam, Christian Buske, Roger G. Owen, Véronique Leblond, Judith Trotman, Gisoo Barnes, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Jeffrey V. Matous
Journal: Blood Advances
Blood Adv (2025) 9 (4): 722–728.
https://doi.org/10.1182/bloodadvances.2024014115
Published: 2025
Journal Articles

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Free
Clinical Trials & Observations
Maciej Tatarczuch, Mark Waltham, Jake Shortt, Galina Polekhina, Eliza A. Hawkes, Shir-Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen S. Opat, Gareth P. Gregory
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3531–3539.
https://doi.org/10.1182/bloodadvances.2022009412
Published: 2023
Includes: Supplemental data
Journal Articles

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL

Free
Clinical Trials & Observations
Jemima H. Miller, Michael Gilbertson, Michael P. MacManus, Andrew Wirth, Stephen S. Opat, Gareth P. Gregory
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5112–5115.
https://doi.org/10.1182/bloodadvances.2021005061
Published: 2021
Includes: Supplemental data
Journal Articles

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Free
Clinical Trials & Observations
Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S. Kaplan, James D. McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V. Catalano, Sanjeev D. Chunilal, Anna Johnston, Stephen S. Opat, Jake Shortt
Journal: Blood Advances
Blood Adv (2016) 1 (1): 31–35.
https://doi.org/10.1182/bloodadvances.2016001412
Published: 2016